Livtone
Natural health product licensed in Canada
- Licence holder
- Ayush Herbs Inc.
- NPN or DIN-HM
- 80089038
- Status
- Active licence
- Licence date
- 5 November 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Silybum marianum Source : Graine(s) Potency : 80 % Silymarin | 25 mg | Not calculated |
| Andrographis paniculata Source : Sommité Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| Raphanus sativus Source : Racine Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg | 25 mg | Not calculated |
| Eclipta prostrata Source : Sommité Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| Tinospora cordifolia Source : Tige Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
| Phyllanthus amarus Source : Plante Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 250 mg | 25 mg | Not calculated |
| Akanda Source : Feuille Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Terminalia chebula Source : Fruit Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 100 mg | 25 mg | Not calculated |
| Picrorhiza kurrooa Source : Racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 500 mg | 50 mg | Not calculated |
| Phyllanthus emblica Source : Fruit Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 500 mg | 25 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Dioxyde de silicium, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 2 days |
Uses authorised in Canada
Source of antioxidants. Amla, Bohera and Harad are traditionally used in Ayurvedic Medicine as Rasayana (rejuvenative tonic). Amla, Bohera and Harad are traditionally used in Ayruvedic Medicine as a digestive tonic to promote digestive fire, increase apetite and aid in digestion (stomachic). Picrorhiza is traditionally used in Ayurvedic Medicineas a hepatoprotectant/liver protectant. Used in Herbal Medicine as an Adaptogen to help increase energy and resistance to stress (e.g. in case of mental and physical fatigue related to stress).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have heart disease, high or low blood pressure, kidney or liver disorder, diabetes or edema (swelling of hands, face and feet) or are taking products containing diuretics, do not use.
- Effets indésirables connus
Laxative and/or diuretic effect may occur, in which case, discontinue use. Hypersensitivity, such as allergy, has been known to occur; in which case, discontinue use. Gastrointestinal discomfort and headache have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If you have or develop nausea, fever or vomiting, consult a health care practitioner. If you experience abdominal pain, cramps, spasms and/or diarrhoea while using this product, reduce dose or discontinue use. Stop use and seek medical attention immediately if you experience dizziness, confusion, muscle weakness or pain, abnormal heart beat and/or difficulty breathing.
Source
Official Health Canada record, licence 80089038
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.